RBC on Inspire Medical Systems (INSP): 'Solid Q4 EPS Beat; Profitability Metrics Continue to Outperform'
Tweet Send to a Friend
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $260.00 price target on Inspire Medical Systems (NYSE: INSP).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
